文献速递鼻科

局部肾上腺素在内镜鼻窦手术中的结局与并发症:系统评价与Meta分析

Outcomes and Complications with Topical Epinephrine in Endoscopic Sinus Surgery: A Systematic Review and Meta-analysis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2020-04-14

该系统评价与Meta分析纳入9项研究共5043例成人内镜鼻窦手术患者,评估局部肾上腺素的安全性和疗效。局部肾上腺素总体安全且止血可接受,高浓度止血更优,但心血管疾病患者需谨慎。

要点

  • 局部肾上腺素在内镜鼻窦手术中总体安全,主要并发症率0.06%。
  • 高浓度(>1:10000)组术中平均出血量低于低浓度组(≤1:10000)。
  • 心血管疾病患者或联用其他血管收缩剂时需谨慎。

核心结论

  • 局部肾上腺素在内镜鼻窦手术中通常安全且提供可接受的止血效果。
  • 较高浓度(>1:10000)比较低浓度(≤1:10000)提供更好的止血。
  • 对于已有心血管疾病或联用其他局部或注射血管收缩剂的患者建议谨慎。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Embase和Ovid MEDLINE数据库至2019年1月。
  • 纳入非病例报告的英文文章,研究成人内镜鼻窦手术中局部肾上腺素作为局部血管收缩剂的效果。
  • 采用PRISMA文献选择流程,共识别2216篇文章,9项研究符合纳入标准,涉及5043例患者。

主要发现

  • 所有9项研究评估了局部肾上腺素的安全性,其中5项检查了疗效。
  • 术中平均出血量(ABL)范围为60至426 mL。
  • 局部肾上腺素浓度从1:1000到1:100000不等,发现3例主要并发症,发生率为0.06%。
  • 未报告眼科、眶部或颅底损伤,也未报告脑脊液漏。

关键数值与推荐

  • 局部肾上腺素浓度范围1:1000至1:100000。
  • 主要并发症率为0.06%。
  • 高浓度组(>1:10000)估计平均ABL为119.4 mL(95%CI 39.1-199.6)。

临床怎么用

  • 局部肾上腺素可用于成人内镜鼻窦手术止血,高浓度(>1:10000)止血效果更优。
  • 对已有心血管疾病或联用其他局部或注射血管收缩剂的患者应谨慎使用。
  • 需要更多前瞻性比较研究来确定内镜鼻窦手术中肾上腺素的理想止血浓度。

局限性

  • 需要更多前瞻性比较研究来确定内镜鼻窦手术中肾上腺素的理想止血浓度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the safety and efficacy of topical epinephrine in adults undergoing endoscopic sinus surgery (ESS). DATA SOURCES: PubMed, Embase, and Ovid MEDLINE online databases. REVIEW METHODS: Non-case report English articles studying the effects of topical epinephrine as the topical vasoconstrictor used in adult ESS were found from the online databases through January 2019. The PRISMA literature selection process was used (Preferred Reporting Items for Systematic Reviews and Meta-analyses). RESULTS: An overall 2216 articles were identified, with 9 meeting inclusion criteria involving a total of 5043 patients. All 9 studies assessed the safety of topical epinephrine, while 5 examined efficacy. Intraoperative average blood loss (ABL) ranged from 60 to 426 mL. Topical epinephrine concentrations varied from 1:1000 to 1:100,000, and 3 major complications were found for a rate of 0.06%. There were no reports of ophthalmic, orbital, or skull base injury, nor were there reports of cerebrospinal fluid leaks. A meta-analysis was performed on the 4 studies examining ABL. Estimated mean (95% CI) ABL was 119.4 mL (39.1-199.6) in the higher-concentration cohort (>1:10,000) and 372.2 mL (296.8-447.5) in the lower-concentration cohort (≤1:10,000) (P = .001). CONCLUSION: Topical epinephrine is generally safe and provides acceptable hemostasis during ESS, with higher concentrations (>1:10,000) providing improved hemostasis. Caution is advised for its use in patients with preexisting cardiovascular disease or in combination with other topical or injected vasoconstrictive agents. More prospective comparative studies are necessary to determine the ideal hemostatic concentration of epinephrine in ESS.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Nesbitt NB, Noller MW, Watson NL, et al. Outcomes and Complications with Topical Epinephrine in Endoscopic Sinus Surgery: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2020. PMID: 32284027. doi:10.1177/0194599820915478

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。